This frequency is higher than the reported 17p13/TP53 deletion rate in ALK-negative ALCL, suggesting a possible association between TP53 deletion and the leukemic phase of ALK-negative ALCL. This evidence concerns the gene ALK and anaplastic large cell lymphoma.